
Max India Limited (MAXIND) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
415.2M
Gross Profit
277.1M
66.74%
Operating Income
-450.5M
-108.50%
Net Income
-460.9M
-111.01%
Balance Sheet Metrics
Total Assets
6.3B
Total Liabilities
2.7B
Shareholders Equity
3.6B
Debt to Equity
0.76
Cash Flow Metrics
Revenue & Profitability Trend
Max India Limited Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.5B | 1.6B | 1.8B | 1.7B | 974.9M |
Cost of Goods Sold | 327.2M | 635.3M | 914.2M | 1.3B | 174.7M |
Gross Profit | 1.1B | 942.7M | 904.9M | 400.2M | 800.2M |
Gross Margin % | 77.5% | 59.7% | 49.7% | 23.7% | 82.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 607.3M | 391.0M | 254.2M | 211.1M | 259.6M |
Other Operating Expenses | 699.1M | 221.4M | 159.8M | 143.4M | 103.8M |
Total Operating Expenses | 1.3B | 612.3M | 414.1M | 354.5M | 363.4M |
Operating Income | -1.4B | -642.0M | -199.6M | -677.3M | -623.2M |
Operating Margin % | -94.4% | -40.7% | -11.0% | -40.1% | -63.9% |
Non-Operating Items | |||||
Interest Income | - | 249.8M | 222.4M | 141.4M | 106.0M |
Interest Expense | 80.6M | 12.4M | 38.4M | 70.5M | 215.6M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -1.4B | -490.3M | -30.1M | -180.3M | -637.8M |
Income Tax | 18.1M | 73.4M | 73.7M | -18.9M | -106.6M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -1.4B | -563.8M | -103.8M | -161.4M | -531.2M |
Net Margin % | -96.5% | -35.7% | -5.7% | -9.5% | -54.5% |
Key Metrics | |||||
EBITDA | -991.0M | -250.3M | 100.5M | -482.0M | -437.3M |
EPS (Basic) | ₹-30.70 | ₹-13.08 | ₹-2.18 | ₹-3.00 | ₹-9.88 |
EPS (Diluted) | ₹-30.70 | ₹-13.08 | ₹-2.18 | ₹-3.00 | ₹-9.88 |
Basic Shares Outstanding | 45731449 | 43114000 | 47568000 | 53786000 | 53786000 |
Diluted Shares Outstanding | 45731449 | 43114000 | 47568000 | 53786000 | 53786000 |
Income Statement Trend
Max India Limited Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 227.0M | 1.2B | 887.3M | 137.8M | 241.1M |
Short-term Investments | 1.7B | 1.8B | 3.0B | 3.8B | 4.2B |
Accounts Receivable | 222.0M | 49.4M | 28.6M | 57.1M | 74.2M |
Inventory | 166.4M | 61.3M | 510.1M | 1.3B | 2.5B |
Other Current Assets | 338.0M | 250.6M | 89.5M | 97.6M | 690.2M |
Total Current Assets | 2.6B | 3.4B | 4.6B | 5.5B | 7.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.5B | 1.1B | 906.6M | 852.7M | 893.2M |
Goodwill | 168.0M | 134.0M | 4.9M | 5.0M | 4.6M |
Intangible Assets | 165.6M | 131.5M | 2.5M | 2.5M | 2.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 14.9M | 28.6M | 610.4M | 605.3M | 4.1M |
Total Non-Current Assets | 3.7B | 3.4B | 2.9B | 3.1B | 2.7B |
Total Assets | 6.3B | 6.8B | 7.5B | 8.6B | 10.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 309.9M | 235.4M | 109.0M | 95.1M | 241.4M |
Short-term Debt | 64.1M | 44.6M | 44.3M | 38.3M | 380.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 143.7M | 27.6M | 40.5M | 34.9M | 22.6M |
Total Current Liabilities | 1.7B | 1.4B | 1.6B | 1.5B | 2.3B |
Non-Current Liabilities | |||||
Long-term Debt | 958.9M | 391.1M | 408.7M | 569.3M | 1.1B |
Deferred Tax Liabilities | 10.3M | 11.4M | 10.0M | 0 | 38.4M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 1.1B | 531.6M | 498.5M | 637.6M | 1.2B |
Total Liabilities | 2.7B | 1.9B | 2.1B | 2.2B | 3.4B |
Equity | |||||
Common Stock | 435.9M | 431.7M | 430.3M | 537.9M | 537.9M |
Retained Earnings | - | -839.0M | -275.1M | -166.4M | -28.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.6B | 4.9B | 5.4B | 6.4B | 6.5B |
Key Metrics | |||||
Total Debt | 1.0B | 435.7M | 453.0M | 607.6M | 1.4B |
Working Capital | 952.9M | 2.0B | 3.0B | 4.0B | 5.0B |
Balance Sheet Composition
Max India Limited Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -1.3B | -490.5M | -30.1M | -129.0M | -555.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 26.5M | 57.0M | 22.1M | 13.5M | 0 |
Working Capital Changes | -55.5M | -429.0M | 817.1M | 1.0B | 1.1B |
Operating Cash Flow | -1.6B | -1.1B | 622.5M | 853.4M | 681.4M |
Investing Activities | |||||
Capital Expenditures | -354.1M | -287.0M | -30.9M | -28.0M | -113.4M |
Acquisitions | -70.3M | 80.4M | 0 | -2.9M | 132.8M |
Investment Purchases | -490.3M | -872.9M | -1.2B | -2.8B | -3.1B |
Investment Sales | 1.1B | 2.1B | 2.1B | 3.2B | 3.3B |
Investing Cash Flow | 253.8M | 1.1B | 867.3M | 454.0M | 230.9M |
Financing Activities | |||||
Share Repurchases | - | 0 | -914.4M | 0 | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | 0 |
Debt Repayment | - | -215.2M | -179.5M | -817.9M | -481.5M |
Financing Cash Flow | 27.9M | -202.9M | -1.1B | -838.3M | -481.5M |
Free Cash Flow | -1.6B | -1.3B | 657.5M | 634.8M | 609.2M |
Net Change in Cash | -1.3B | -229.4M | 382.9M | 469.1M | 430.8M |
Cash Flow Trend
Max India Limited Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-7.15
Price to Book
2.67
Price to Sales
7.04
PEG Ratio
-0.05
Profitability Ratios
Profit Margin
-85.52%
Operating Margin
-85.64%
Return on Equity
-32.99%
Return on Assets
-9.13%
Financial Health
Current Ratio
2.15
Debt to Equity
28.52
Beta
0.22
Per Share Data
EPS (TTM)
₹-30.72
Book Value per Share
₹83.04
Revenue per Share
₹38.01
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
maxind | 11.6B | -7.15 | 2.67 | -32.99% | -85.52% | 28.52 |
Max Healthcare | 1.3T | 114.44 | 13.01 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.1T | 74.03 | 13.07 | 18.85% | 6.63% | 90.89 |
Indraprastha Medical | 46.6B | 26.86 | 7.26 | 29.97% | 11.87% | 5.49 |
Shalby | 22.2B | 1,219.53 | 2.04 | 0.19% | 0.57% | 9.69 |
Dr. Agarwal's Eye | 20.7B | 37.47 | 9.80 | 29.80% | 13.76% | 158.94 |
Financial data is updated regularly. All figures are in the company's reporting currency.